Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg and Aarhus, Denmark.
Am J Respir Crit Care Med. 2010 Mar 1;181(5):514-21. doi: 10.1164/rccm.200905-0778OC. Epub 2009 Dec 10.
Few population-based data are available regarding nontuberculous mycobacteria (NTM) pulmonary disease epidemiology and prognosis.
To examine NTM pulmonary colonization incidence, disease incidence, and prognostic factors.
All adults in Denmark with at least one NTM-positive pulmonary specimen during 1997 to 2008 were identified using national medical databases and were categorized as having possible or definite NTM disease or colonization.
We calculated annual age-standardized NTM incidence rates and adjusted hazard ratios (HR) of death associated with patient age, sex, comorbidity, NTM species, and NTM disease status. Of 1,282 adults with 2,666 NTM-positive pulmonary specimens, 335 (26%) had definite NTM disease, 238 (19%) possible disease, and 709 (55%) colonization only. NTM incidence rates decreased until 2002, followed by an increase from 2003 to 2008 (mean annual rate per 100,000 person-years: NTM colonization, 1.36; NTM disease, 1.08). Five-year mortality after definite NTM disease was 40.1%. After controlling for potential confounders, 5-year mortality for definite NTM disease was slightly higher than for NTM colonization (adjusted hazard ratio [HR], 1.15; 95% confidence interval [CI], 0.90-1.51). Mycobacterium xenopi was associated with worse prognosis (adjusted HR, 1.51; 95% CI, 0.99-2.33) than the reference Mycobacterium avium complex. High comorbidity level (HR, 2.97), age greater than or equal to 65 years (HR, 9.17), and male sex (female sex HR, 0.73) were predictors of death.
NTM disease incidence has remained unchanged in Denmark over the past 12 years. Patients with NTM colonization and disease have similarly poor prognosis. Negative prognostic factors include high levels of comorbidity, advanced age, male sex, and M. xenopi.
关于非结核分枝杆菌(NTM)肺部疾病的流行病学和预后,目前仅有少量基于人群的数据。
研究 NTM 肺部定植的发生率、疾病发生率和预后因素。
通过国家医疗数据库,确定了 1997 年至 2008 年间至少有一次 NTM 阳性肺部标本的丹麦所有成年人,并将其分为可能或明确的 NTM 疾病或定植。
我们计算了每年按年龄标准化的 NTM 发病率和与患者年龄、性别、合并症、NTM 物种和 NTM 疾病状态相关的死亡调整后的危险比(HR)。在 1282 名成年人的 2666 份 NTM 阳性肺部标本中,335 例(26%)患有明确的 NTM 疾病,238 例(19%)患有可能的疾病,709 例(55%)仅为定植。NTM 发病率在 2002 年之前下降,随后在 2003 年至 2008 年之间上升(每 100,000 人年的平均年发病率:NTM 定植率为 1.36,NTM 疾病率为 1.08)。明确的 NTM 疾病后 5 年死亡率为 40.1%。在控制了潜在的混杂因素后,明确的 NTM 疾病后 5 年死亡率略高于 NTM 定植(调整后的 HR,1.15;95%置信区间 [CI],0.90-1.51)。与参比的鸟分枝杆菌复合群相比,耻垢分枝杆菌的预后较差(调整后的 HR,1.51;95%CI,0.99-2.33)。高合并症水平(HR,2.97)、年龄大于或等于 65 岁(HR,9.17)和男性(女性 HR,0.73)是死亡的预测因素。
在过去的 12 年中,丹麦的 NTM 疾病发病率保持不变。患有 NTM 定植和疾病的患者预后同样较差。预后不良的负面因素包括高水平的合并症、年龄较大、男性和耻垢分枝杆菌。